Medical - Equipment & Services
Compare Stocks
4 / 10Stock Comparison
NVST vs MMSI vs ITGR vs HSIC
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
Medical - Devices
Medical - Distribution
NVST vs MMSI vs ITGR vs HSIC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Equipment & Services | Medical - Instruments & Supplies | Medical - Devices | Medical - Distribution |
| Market Cap | $4.04B | $3.72B | $3.03B | $8.09B |
| Revenue (TTM) | $2.81B | $1.54B | $1.85B | $13.18B |
| Net Income (TTM) | $68M | $139M | $142M | $398M |
| Gross Margin | 55.1% | 48.7% | 23.3% | 29.1% |
| Operating Margin | 9.0% | 12.2% | 10.4% | 5.8% |
| Forward P/E | 17.2x | 15.1x | 13.5x | 13.2x |
| Total Debt | $1.71B | $898M | $1.40B | $3.69B |
| Cash & Equiv. | $1.21B | $449M | $17M | $156M |
NVST vs MMSI vs ITGR vs HSIC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Envista Holdings Co… (NVST) | 100 | 114.7 | +14.7% |
| Merit Medical Syste… (MMSI) | 100 | 136.2 | +36.2% |
| Integer Holdings Co… (ITGR) | 100 | 111.3 | +11.3% |
| Henry Schein, Inc. (HSIC) | 100 | 116.6 | +16.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NVST vs MMSI vs ITGR vs HSIC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NVST is the #2 pick in this set and the best alternative if momentum is your priority.
- +44.2% vs MMSI's -33.8%
MMSI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 0.71
- Rev growth 11.7%, EPS growth 4.9%, 3Y rev CAGR 9.6%
- 214.6% 10Y total return vs ITGR's 165.1%
- Lower volatility, beta 0.71, Low D/E 56.7%, current ratio 4.34x
ITGR is the clearest fit if your priority is valuation efficiency.
- PEG 3.08 vs NVST's 11.53
HSIC is the clearest fit if your priority is value.
- Lower P/E (13.2x vs 15.1x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.7% revenue growth vs HSIC's 4.0% | |
| Value | Lower P/E (13.2x vs 15.1x) | |
| Quality / Margins | 9.0% margin vs NVST's 2.4% | |
| Stability / Safety | Beta 0.71 vs NVST's 1.65 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +44.2% vs MMSI's -33.8% | |
| Efficiency (ROA) | 5.2% ROA vs NVST's 1.2%, ROIC 7.2% vs 4.8% |
NVST vs MMSI vs ITGR vs HSIC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NVST vs MMSI vs ITGR vs HSIC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MMSI leads in 2 of 6 categories
HSIC leads 1 • ITGR leads 1 • NVST leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MMSI leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HSIC is the larger business by revenue, generating $13.2B annually — 8.5x MMSI's $1.5B. MMSI is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to NVST's 2.4%. On growth, NVST holds the edge at +14.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.8B | $1.5B | $1.8B | $13.2B |
| EBITDAEarnings before interest/tax | $342M | $290M | $328M | $1.1B |
| Net IncomeAfter-tax profit | $68M | $139M | $142M | $398M |
| Free Cash FlowCash after capex | $220M | $274M | $168M | $561M |
| Gross MarginGross profit ÷ Revenue | +55.1% | +48.7% | +23.3% | +29.1% |
| Operating MarginEBIT ÷ Revenue | +9.0% | +12.2% | +10.4% | +5.8% |
| Net MarginNet income ÷ Revenue | +2.4% | +9.0% | +7.7% | +3.0% |
| FCF MarginFCF ÷ Revenue | +7.8% | +17.8% | +9.1% | +4.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +14.4% | +7.8% | +0.8% | +7.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +130.0% | +38.8% | +172.7% | +14.9% |
Valuation Metrics
HSIC leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 21.6x trailing earnings, HSIC trades at a 75% valuation discount to NVST's 86.7x P/E. Adjusting for growth (PEG ratio), HSIC offers better value at 6.84x vs NVST's 58.08x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $4.0B | $3.7B | $3.0B | $8.1B |
| Enterprise ValueMkt cap + debt − cash | $4.5B | $4.2B | $4.4B | $11.6B |
| Trailing P/EPrice ÷ TTM EPS | 86.73x | 29.26x | 30.42x | 21.56x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.21x | 15.05x | 13.55x | 13.25x |
| PEG RatioP/E ÷ EPS growth rate | 58.08x | — | 6.91x | 6.84x |
| EV / EBITDAEnterprise value multiple | 13.28x | 13.06x | 13.15x | 10.87x |
| Price / SalesMarket cap ÷ Revenue | 1.49x | 2.45x | 1.64x | 0.61x |
| Price / BookPrice ÷ Book value/share | 1.32x | 2.38x | 1.79x | 1.79x |
| Price / FCFMarket cap ÷ FCF | 17.54x | 17.24x | 28.78x | 14.12x |
Profitability & Efficiency
MMSI leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MMSI delivers a 8.9% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $2 for NVST. NVST carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to ITGR's 0.80x. On the Piotroski fundamental quality scale (0–9), NVST scores 7/9 vs HSIC's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.2% | +8.9% | +8.2% | +8.2% |
| ROA (TTM)Return on assets | +1.2% | +5.2% | +4.2% | +3.6% |
| ROICReturn on invested capital | +4.8% | +7.2% | +5.4% | +7.1% |
| ROCEReturn on capital employed | +4.9% | +7.9% | +6.9% | +9.8% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.55x | 0.57x | 0.80x | 0.77x |
| Net DebtTotal debt minus cash | $496M | $450M | $1.4B | $3.5B |
| Cash & Equiv.Liquid assets | $1.2B | $449M | $17M | $156M |
| Total DebtShort + long-term debt | $1.7B | $898M | $1.4B | $3.7B |
| Interest CoverageEBIT ÷ Interest expense | 12.76x | 10.74x | 5.07x | 4.59x |
Total Returns (Dividends Reinvested)
ITGR leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MMSI five years ago would be worth $9,644 today (with dividends reinvested), compared to $5,340 for NVST. Over the past 12 months, NVST leads with a +44.2% total return vs MMSI's -33.8%. The 3-year compound annual growth rate (CAGR) favors ITGR at 2.9% vs NVST's -11.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +12.0% | -27.9% | +14.5% | -8.2% |
| 1-Year ReturnPast 12 months | +44.2% | -33.8% | -26.1% | +5.9% |
| 3-Year ReturnCumulative with dividends | -30.3% | -26.5% | +8.8% | -11.7% |
| 5-Year ReturnCumulative with dividends | -46.6% | -3.6% | -7.5% | -12.5% |
| 10-Year ReturnCumulative with dividends | -13.1% | +214.6% | +165.1% | +5.3% |
| CAGR (3Y)Annualised 3-year return | -11.3% | -9.8% | +2.9% | -4.0% |
Risk & Volatility
Evenly matched — NVST and MMSI each lead in 1 of 2 comparable metrics.
Risk & Volatility
MMSI is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than NVST's 1.65 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVST currently trades 79.8% from its 52-week high vs MMSI's 62.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.63x | 0.66x | 0.71x | 0.72x |
| 52-Week HighHighest price in past year | $30.42 | $100.19 | $123.78 | $89.29 |
| 52-Week LowLowest price in past year | $16.33 | $59.74 | $62.00 | $61.95 |
| % of 52W HighCurrent price vs 52-week peak | +79.8% | +62.2% | +71.0% | +79.0% |
| RSI (14)Momentum oscillator 0–100 | 55.1 | 34.9 | 50.9 | 39.1 |
| Avg Volume (50D)Average daily shares traded | 2.4M | 769K | 628K | 1.2M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: NVST as "Hold", MMSI as "Buy", ITGR as "Buy", HSIC as "Hold". Consensus price targets imply 52.4% upside for MMSI (target: $95) vs 11.2% for NVST (target: $27).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $27.00 | $95.00 | $98.00 | $85.43 |
| # AnalystsCovering analysts | 19 | 14 | 14 | 32 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +4.1% | 0.0% | +1.7% | +10.5% |
MMSI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HSIC leads in 1 (Valuation Metrics). 1 tied.
NVST vs MMSI vs ITGR vs HSIC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NVST or MMSI or ITGR or HSIC a better buy right now?
For growth investors, Merit Medical Systems, Inc.
(MMSI) is the stronger pick with 11. 7% revenue growth year-over-year, versus 4. 0% for Henry Schein, Inc. (HSIC). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 6x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate Merit Medical Systems, Inc. (MMSI) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NVST or MMSI or ITGR or HSIC?
On trailing P/E, Henry Schein, Inc.
(HSIC) is the cheapest at 21. 6x versus Envista Holdings Corp at 86. 7x. On forward P/E, Henry Schein, Inc. is actually cheaper at 13. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Integer Holdings Corporation wins at 3. 08x versus Envista Holdings Corp's 11. 53x.
03Which is the better long-term investment — NVST or MMSI or ITGR or HSIC?
Over the past 5 years, Merit Medical Systems, Inc.
(MMSI) delivered a total return of -3. 6%, compared to -46. 6% for Envista Holdings Corp (NVST). Over 10 years, the gap is even starker: MMSI returned +209. 3% versus NVST's -13. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NVST or MMSI or ITGR or HSIC?
By beta (market sensitivity over 5 years), Merit Medical Systems, Inc.
(MMSI) is the lower-risk stock at 0. 66β versus Envista Holdings Corp's 1. 63β — meaning NVST is approximately 147% more volatile than MMSI relative to the S&P 500. On balance sheet safety, Envista Holdings Corp (NVST) carries a lower debt/equity ratio of 55% versus 80% for Integer Holdings Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — NVST or MMSI or ITGR or HSIC?
By revenue growth (latest reported year), Merit Medical Systems, Inc.
(MMSI) is pulling ahead at 11. 7% versus 4. 0% for Henry Schein, Inc. (HSIC). On earnings-per-share growth, the picture is similar: Envista Holdings Corp grew EPS 104. 3% year-over-year, compared to -15. 0% for Integer Holdings Corporation. Over a 3-year CAGR, ITGR leads at 11. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NVST or MMSI or ITGR or HSIC?
Merit Medical Systems, Inc.
(MMSI) is the more profitable company, earning 8. 5% net margin versus 1. 7% for Envista Holdings Corp — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MMSI leads at 12. 2% versus 5. 7% for HSIC. At the gross margin level — before operating expenses — NVST leads at 55. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NVST or MMSI or ITGR or HSIC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Integer Holdings Corporation (ITGR) is the more undervalued stock at a PEG of 3. 08x versus Envista Holdings Corp's 11. 53x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Henry Schein, Inc. (HSIC) trades at 13. 2x forward P/E versus 17. 2x for Envista Holdings Corp — 4. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMSI: 52. 4% to $95. 00.
08Which pays a better dividend — NVST or MMSI or ITGR or HSIC?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is NVST or MMSI or ITGR or HSIC better for a retirement portfolio?
For long-horizon retirement investors, Merit Medical Systems, Inc.
(MMSI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 66), +209. 3% 10Y return). Envista Holdings Corp (NVST) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MMSI: +209. 3%, NVST: -13. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NVST and MMSI and ITGR and HSIC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.